Physiological barriers and strategies of lipid‐based nanoparticles for nucleic acid drug delivery
Lipid‐based nanoparticles (LBNPs) are currently the most promising vehicles for nucleic
acid drug (NAD) delivery. Although their clinical applications have achieved success, the …
acid drug (NAD) delivery. Although their clinical applications have achieved success, the …
Intelligent biomaterialomics: molecular design, manufacturing, and biomedical applications
Y Yi, HW An, H Wang - Advanced Materials, 2024 - Wiley Online Library
Materialomics integrates experiment, theory, and computation in a high‐throughput manner,
and has changed the paradigm for the research and development of new functional …
and has changed the paradigm for the research and development of new functional …
High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models
Lipid nanoparticles for delivering mRNA therapeutics hold immense promise for the
treatment of a wide range of lung-associated diseases. However, the lack of effective …
treatment of a wide range of lung-associated diseases. However, the lack of effective …
Personalized cancer nanomedicine: Overcoming biological barriers for intracellular delivery of biopharmaceuticals
AM López‐Estévez, P Lapuhs… - Advanced …, 2024 - Wiley Online Library
The success of personalized medicine in oncology relies on using highly effective and
precise therapeutic modalities such as small interfering RNA (siRNA) and monoclonal …
precise therapeutic modalities such as small interfering RNA (siRNA) and monoclonal …
Cellular Trafficking of Nanotechnology‐Mediated mRNA Delivery
P Huang, H Deng, C Wang, Y Zhou… - Advanced …, 2024 - Wiley Online Library
Messenger RNA (mRNA)‐based therapy has emerged as a powerful, safe, and rapidly
scalable therapeutic approach that involves technologies for both mRNA itself and the …
scalable therapeutic approach that involves technologies for both mRNA itself and the …
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
J Liu, H Cabral, P Mi - Advanced Drug Delivery Reviews, 2024 - Elsevier
The cellular barriers are major bottlenecks for bioactive compounds entering into cells to
accomplish their biological functions, which limits their biomedical applications …
accomplish their biological functions, which limits their biomedical applications …
Dual-functional DNA nanogels for anticancer drug delivery
H Zhu, J Wu, J Zhao, L Yu, BR Liyarita, X Xu, Y Xiao… - Acta Biomaterialia, 2024 - Elsevier
DNA hydrogels with unique sequence programmability on nucleic acid framework manifest
remarkable attributes, such as high payload capacities, biocompatibility and biosafety. The …
remarkable attributes, such as high payload capacities, biocompatibility and biosafety. The …
Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy
S Qi, X Zhang, X Yu, L Jin, K Yang, Y Wang… - Advanced …, 2024 - Wiley Online Library
Dendritic cell (DC) maturation is a crucial process for antigen presentation and the initiation
of T cell‐mediated immune responses. Toll‐like receptors play pivotal roles in stimulating …
of T cell‐mediated immune responses. Toll‐like receptors play pivotal roles in stimulating …
The next-generation DNA vaccine platforms and delivery systems: Advances, challenges and prospects
B Lu, JM Lim, B Yu, S Song, P Neeli… - Frontiers in …, 2024 - frontiersin.org
Vaccines have proven effective in the treatment and prevention of numerous diseases.
However, traditional attenuated and inactivated vaccines suffer from certain drawbacks such …
However, traditional attenuated and inactivated vaccines suffer from certain drawbacks such …
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
KKW To, Z Huang, H Zhang, CR Ashby Jr, L Fu - Drug Resistance Updates, 2024 - Elsevier
Multidrug resistance (MDR) is one of the primary factors that produces treatment failure in
patients receiving cancer chemotherapy. MDR is a complex multifactorial phenomenon …
patients receiving cancer chemotherapy. MDR is a complex multifactorial phenomenon …